45 results
DEFM14A
AMTI
Applied Molecular Transport Inc.
21 Nov 23
Proxy related to merger
9:16am
) such U.S. Holder’s adjusted tax basis in its shares of AMTI common stock exchanged pursuant to the Merger. Such gain or loss will be long-term capital gain … is a complex process and represents a critical path to creating biologic product candidates and a key component of AMTI’s long-term success. AMTI has
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
and long term liabilities, including but not limited to accounts payable and accrued expenses and promised but unpaid capital expenditures (without … Board and leadership team believe this will be a transformational transaction that will be beneficial to all of our stakeholders in the near and long
8-K
EX-99.1
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
this will be a transformational transaction that will be beneficial to all of our stakeholders in the near and long term. Importantly, this transaction
8-K
EX-2.1
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
to the One Tower Lease, minus (c) the sum of the Company’s short and long term liabilities, including but not limited to accounts payable and accrued
8-K
EX-10.1
5ikpe9g 0l8dppp6
24 Jul 23
Departure of Directors or Certain Officers
4:01pm
8-K
EX-1.1
zyk2d88zvw40ojn
28 Jan 22
Entry into a Material Definitive Agreement
12:00am
DEF 14A
urx5q w5jlh4l9tu57qr
7 Apr 21
Definitive proxy
4:05pm